{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:58:49Z","timestamp":1791194329427,"version":"4.1.0"},"reference-count":85,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.antiviral.2014.01.006","type":"journal-article","created":{"date-parts":[[2014,1,23]],"date-time":"2014-01-23T04:00:37Z","timestamp":1390449637000},"page":"40-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Molecular modeling and residue interaction network studies on the mechanism of binding and resistance of the HCV NS5B polymerase mutants to VX-222 and ANA598"],"prefix":"10.1016","volume":"104","author":[{"given":"Weiwei","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingzu","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanxiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2014.01.006_b0005","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1570-9639(02)00433-8","article-title":"The essential role of C-terminal residues in regulating the activity of hepatitis C virus RNA-dependent RNA polymerase","volume":"1601","author":"Adachi","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.antiviral.2014.01.006_b0010","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1021\/ci900012k","article-title":"Molecular dynamics and free energy studies on the wild-type and mutated HIV-1 protease complexed with four approved drugs: mechanism of binding and drug resistance","volume":"49","author":"Alcaro","year":"2009","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.antiviral.2014.01.006_b0015","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1021\/ci060090c","article-title":"Molecular dynamic and free energy studies of primary resistance mutations in HIV-1 protease\u2212ritonavir complexes","volume":"46","author":"Aruksakunwong","year":"2006","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.antiviral.2014.01.006_b0020","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/bioinformatics\/btm554","article-title":"Computing topological parameters of biological networks","volume":"24","author":"Assenov","year":"2008","journal-title":"Bioinformatics"},{"key":"10.1016\/j.antiviral.2014.01.006_b0025","doi-asserted-by":"crossref","first-page":"8435","DOI":"10.1021\/bi900729a","article-title":"Quantitative prediction of fold resistance for inhibitors of EGFR","volume":"48","author":"Balius","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2014.01.006_b0030","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1021\/j100142a004","article-title":"A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model","volume":"97","author":"Bayly","year":"1993","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.antiviral.2014.01.006_b0035","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1016\/j.febslet.2007.05.021","article-title":"Network analysis of protein dynamics","volume":"581","author":"B\u00f6de","year":"2007","journal-title":"FEBS Lett."},{"key":"10.1016\/j.antiviral.2014.01.006_b0040","doi-asserted-by":"crossref","first-page":"13034","DOI":"10.1073\/pnas.96.23.13034","article-title":"Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus","volume":"96","author":"Bressanelli","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2014.01.006_b0045","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1021\/ct9004678","article-title":"Decomposing the energetic impact of drug resistant mutations in HIV-1 protease on binding DRV","volume":"6","author":"Cai","year":"2010","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.antiviral.2014.01.006_b0050","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jmb.2011.10.001","article-title":"An objective assessment of conformational variability in complexes of hepatitis C virus polymerase with non-nucleoside inhibitors","volume":"414","author":"Caillet-Saguy","year":"2011","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2014.01.006_b0055","series-title":"AMBER 10","author":"Case","year":"2008"},{"key":"10.1016\/j.antiviral.2014.01.006_b0060","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1021\/ct800068v","article-title":"Origins of resistance conferred by the R292K neuraminidase mutation via molecular dynamics and free energy calculations","volume":"4","author":"Chachra","year":"2008","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.antiviral.2014.01.006_b0065","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/jcc.540161106","article-title":"Application of the multimolecule and multiconformational RESP methodology to biopolymers: charge derivation for DNA, RNA, and proteins","volume":"16","author":"Cieplak","year":"1995","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.antiviral.2014.01.006_b0070","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N\u00b7log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.antiviral.2014.01.006_b0075","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/prot.24154","article-title":"Thumb inhibitor binding eliminates functionally important dynamics in the hepatitis C virus RNA polymerase","volume":"81","author":"Davis","year":"2013","journal-title":"Proteins"},{"key":"10.1016\/j.antiviral.2014.01.006_b0080","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/rmv.1727","article-title":"The race for interferon-free HCV therapies: a snapshot by the spring of 2012","volume":"22","author":"De Clercq","year":"2012","journal-title":"Rev. Med. Virol."},{"issue":"2006","key":"10.1016\/j.antiviral.2014.01.006_b0085","first-page":"0019","article-title":"Residues crucial for maintaining short paths in network communication mediate signaling in proteins","volume":"2","author":"del Sol","year":"2006","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.antiviral.2014.01.006_b0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4103\/0974-777X.52979","article-title":"Association between hepatitis C and hepatocellular carcinoma","volume":"1","author":"D\u2019Oliveira","year":"2009","journal-title":"J. Glob. Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.01.006_b0095","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.tibs.2011.01.002","article-title":"Analyzing and visualizing residue networks of protein structures","volume":"36","author":"Doncheva","year":"2011","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.antiviral.2014.01.006_b0100","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1002\/jcc.10349","article-title":"A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations","volume":"24","author":"Duan","year":"2003","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.antiviral.2014.01.006_b0105","doi-asserted-by":"crossref","first-page":"8070","DOI":"10.1021\/jp9717655","article-title":"Application of the RESP methodology in the parametrization of organic solvents","volume":"102","author":"Fox","year":"1998","journal-title":"J. Phys. Chem. B."},{"key":"10.1016\/j.antiviral.2014.01.006_b0110","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0378-8733(78)90021-7","article-title":"Centrality in social networks conceptual clarification","volume":"1","author":"Freeman","year":"1978","journal-title":"Soc. Netw."},{"key":"10.1016\/j.antiviral.2014.01.006_b0115","doi-asserted-by":"crossref","first-page":"s237","DOI":"10.1002\/hep.1840360730","article-title":"Side effects of therapy of hepatitis C and their management","volume":"36","author":"Fried","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2014.01.006_b0120","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2014.01.006_b0125","series-title":"In Gaussian 09","author":"Frisch","year":"2009"},{"key":"10.1016\/j.antiviral.2014.01.006_b0130","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1021\/ct600151y","article-title":"Computational study of the effects of mutations A156T, D168V, and D168Q on the binding of HCV protease inhibitors","volume":"2","author":"Guo","year":"2006","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.antiviral.2014.01.006_b0135","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-140-5-200403020-00010","article-title":"Peginterferon-\u03b12a and ribavirin combination therapy in chronic hepatitis CA randomized study of treatment duration and ribavirin dose","volume":"140","author":"Hadziyannis","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.antiviral.2014.01.006_b0140","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1021\/jm0609162","article-title":"Molecular dynamics and free energy studies on the wild-type and double mutant HIV-1 protease complexed with amprenavir and two amprenavir-related inhibitors: mechanism for binding and drug resistance","volume":"50","author":"Hou","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2014.01.006_b0145","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/prot.21808","article-title":"Evaluating the potency of HIV-1 protease drugs to combat resistance","volume":"71","author":"Hou","year":"2008","journal-title":"Proteins"},{"key":"10.1016\/j.antiviral.2014.01.006_b0150","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/prot.22192","article-title":"Predicting drug resistance of the HIV-1 protease using molecular interaction energy components","volume":"74","author":"Hou","year":"2009","journal-title":"Proteins"},{"key":"10.1016\/j.antiviral.2014.01.006_b0155","article-title":"Understanding the drug resistance mechanism of hepatitis C virus NS5B to PF-00868554 due to mutations of 423 site: a computational study","author":"Jiao","year":"2013","journal-title":"Mol. Biosyst"},{"key":"10.1016\/j.antiviral.2014.01.006_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.it.2005.11.004","article-title":"CARD games between virus and host get a new player","volume":"27","author":"Johnson","year":"2006","journal-title":"Trends Immunol."},{"key":"10.1016\/j.antiviral.2014.01.006_b0165","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.antiviral.2014.01.006_b0170","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.1021\/jp003919d","article-title":"Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides","volume":"105","author":"Kaminski","year":"2001","journal-title":"J. Phys. Chem. B."},{"key":"10.1016\/j.antiviral.2014.01.006_b0175","doi-asserted-by":"crossref","DOI":"10.1186\/2001-1326-2-9","article-title":"Treatment of hepatitis C virus infection in the future","author":"Kanda","year":"2013","journal-title":"Clin. Transl. Med"},{"key":"10.1016\/j.antiviral.2014.01.006_b0180","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0092-8674(00)81351-3","article-title":"Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide","volume":"87","author":"Kim","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2014.01.006_b0185","article-title":"Preclinical characterization of a novel, potent, and pharmacokinetically appealing nonnucleoside inhibitor of HCV NS5B polymerase. 58th Annu","author":"Kirkovsky","year":"2007","journal-title":"Meet. Am. Assoc. Study Liver Dis"},{"key":"10.1016\/j.antiviral.2014.01.006_b0190","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/PHAR.1046","article-title":"Boceprevir: a novel NS3\/4 protease inhibitor for the treatment of hepatitis C","volume":"32","author":"Klibanov","year":"2012","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.antiviral.2014.01.006_b0195","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1021\/ar000033j","article-title":"Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models","volume":"33","author":"Kollman","year":"2000","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.antiviral.2014.01.006_b0200","doi-asserted-by":"crossref","first-page":"6146","DOI":"10.1128\/JVI.02628-05","article-title":"Selection and characterization of replicon variants dually resistant to thumb- and palm-binding nonnucleoside polymerase inhibitors of the hepatitis C virus","volume":"80","author":"Le Pogam","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.01.006_b0205","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/13305","article-title":"Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site","volume":"6","author":"Lesburg","year":"1999","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.antiviral.2014.01.006_b0210","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1021\/ci300375k","article-title":"Theoretical studies on the susceptibility of oseltamivir against variants of 2009 A\/H1N1 influenza neuraminidase","volume":"52","author":"Li","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.antiviral.2014.01.006_b0215","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1021\/mp100041b","article-title":"In silico identification of the potential drug resistance sites over 2009 influenza A (H1N1) virus neuraminidase","volume":"7","author":"Liu","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.antiviral.2014.01.006_b0220","series-title":"Hepatitis C Virus: From Molecular Virology to Antiviral Therapy","first-page":"167","article-title":"Hepatitis C virus RNA replication","author":"Lohmann","year":"2013"},{"key":"10.1016\/j.antiviral.2014.01.006_b0225","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0092-8674(00)81350-1","article-title":"The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site","volume":"87","author":"Love","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2014.01.006_b0230","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1023\/A:1008763014207","article-title":"Combined molecular mechanical and continuum solvent approach (MM-PBSA\/GBSA) to predict ligand binding","volume":"18","author":"Massova","year":"2000","journal-title":"Perspect. Drug Discov."},{"key":"10.1016\/j.antiviral.2014.01.006_b0235","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.clinthera.2012.07.011","article-title":"Telaprevir: a hepatitis C NS3\/4A protease inhibitor","volume":"34","author":"Matthews","year":"2012","journal-title":"Clin. Ther."},{"key":"10.1016\/j.antiviral.2014.01.006_b0240","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nrd3361","article-title":"Hepatitis C \u2013 pipeline update","volume":"10","author":"Melnikova","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2014.01.006_b0245","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1021\/jm900517t","article-title":"Identification and biological evaluation of a series of 1H-benzo[de]isoquinoline-1,3(2H)-diones as hepatitis C virus NS5B polymerase inhibitors","volume":"52","author":"Ontoria","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2014.01.006_b0250","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1021\/jp994072s","article-title":"Modification of the generalized born model suitable for macromolecules","volume":"104","author":"Onufriev","year":"2000","journal-title":"J. Phys. Chem. B."},{"key":"10.1016\/j.antiviral.2014.01.006_b0255","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1007\/s00894-010-0929-8","article-title":"Prediction of zanamivir efficiency over the possible 2009 influenza A (H1N1) mutants by multiple molecular dynamics simulations and free energy calculations","volume":"17","author":"Pan","year":"2011","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.antiviral.2014.01.006_b0260","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.bbagen.2012.06.001","article-title":"Understanding the drug resistance mechanism of hepatitis C virus NS3\/4A to ITMN-191 due to R155K, A156V, D168A\/E mutations: a computational study","volume":"1820","author":"Pan","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.antiviral.2014.01.006_b0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0010-4655(95)00041-D","article-title":"AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules","volume":"91","author":"Pearlman","year":"1995","journal-title":"Comput. Phys. Commun."},{"key":"10.1016\/j.antiviral.2014.01.006_b0270","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1021\/jm030570k","article-title":"A molecular basis for the selectivity of thiadiazole urea inhibitors with stromelysin-1 and gelatinase-A from generalized born molecular dynamics simulations","volume":"47","author":"Rizzo","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2014.01.006_b0275","doi-asserted-by":"crossref","first-page":"6507","DOI":"10.1021\/jp010454y","article-title":"Extending the applicability of the nonlinear poisson\u2212boltzmann equation: multiple dielectric constants and multivalent ions","volume":"105","author":"Rocchia","year":"2001","journal-title":"J. Phys. Chem. B."},{"key":"10.1016\/j.antiviral.2014.01.006_b0280","doi-asserted-by":"crossref","first-page":"6404","DOI":"10.1016\/j.bmcl.2009.09.045","article-title":"Discovery of tricyclic 5,6-dihydro-1H-pyridin-2-ones as novel, potent, and orally bioavailable inhibitors of HCV NS5B polymerase","volume":"19","author":"Ruebsam","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2014.01.006_b0285","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0021-9991(77)90098-5","article-title":"Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes","volume":"23","author":"Ryckaert","year":"1977","journal-title":"J. Comput. Phys."},{"key":"10.1016\/j.antiviral.2014.01.006_b0290","series-title":"Maestro, Version 9.0","author":"Schr\u00f6dinger","year":"2009"},{"key":"10.1016\/j.antiviral.2014.01.006_b0295","series-title":"LigPrep, Version 2.3","author":"Schr\u00f6dinger","year":"2009"},{"key":"10.1016\/j.antiviral.2014.01.006_b0300","series-title":"Epik, Version 2.0","author":"Schr\u00f6dinger","year":"2009"},{"key":"10.1016\/j.antiviral.2014.01.006_b0305","series-title":"Prime Version 2.1","author":"Schr\u00f6dinger","year":"2009"},{"key":"10.1016\/j.antiviral.2014.01.006_b0310","series-title":"Glide, Version 5.5","author":"Schr\u00f6dinger","year":"2009"},{"key":"10.1016\/j.antiviral.2014.01.006_b0315","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"10.1016\/j.antiviral.2014.01.006_b0320","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1021\/j100058a043","article-title":"Accurate calculation of hydration free energies using macroscopic solvent models","volume":"98","author":"Sitkoff","year":"1994","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.antiviral.2014.01.006_b0325","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1021\/jm201384j","article-title":"Nucleoside, nucleotide, and non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA-polymerase","volume":"55","author":"Sofia","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2014.01.006_b0330","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1517\/14656566.2013.795543","article-title":"Hepatitis C therapy with HCV NS5B polymerase inhibitors","volume":"14","author":"Soriano","year":"2013","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.antiviral.2014.01.006_b0335","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1021\/ja0779250","article-title":"Rapid and accurate prediction of binding free energies for saquinavir-bound HIV-1 proteases","volume":"130","author":"Stoica","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.antiviral.2014.01.006_b0340","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/nature03580","article-title":"Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase","volume":"435","author":"Tellinghuisen","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2014.01.006_b0345","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E","article-title":"Theory and applications of the generalized born solvation model in macromolecular simulations","volume":"56","author":"Tsui","year":"2000","journal-title":"Biopolymers"},{"key":"10.1016\/j.antiviral.2014.01.006_b0350","doi-asserted-by":"crossref","first-page":"061910","DOI":"10.1103\/PhysRevE.65.061910","article-title":"Small-world view of the amino acids that play a key role in protein folding","volume":"65","author":"Vendruscolo","year":"2002","journal-title":"Phys. Rev. E"},{"key":"10.1016\/j.antiviral.2014.01.006_b0355","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1021\/ci300343w","article-title":"Molecular basis of drug resistance in A\/H1N1 virus","volume":"52","author":"Vergara-Jaque","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.antiviral.2014.01.006_b0360","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2174\/138920309787847590","article-title":"Intra and inter-molecular communications through protein structure","volume":"10","author":"Vishveshwara","year":"2009","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.antiviral.2014.01.006_b0365","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.antiviral.2014.01.006_b0370","doi-asserted-by":"crossref","first-page":"R16","DOI":"10.1186\/gb-2008-9-1-r16","article-title":"Molecular basis of telaprevir resistance due to V36 and T54 mutations in the NS3-4A protease of the hepatitis C virus","volume":"9","author":"Welsch","year":"2008","journal-title":"Genome Biol."},{"key":"10.1016\/j.antiviral.2014.01.006_b0375","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1128\/AAC.05184-11","article-title":"Ketoamide resistance and hepatitis C virus fitness in Val55 variants of the NS3 serine protease","volume":"56","author":"Welsch","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2014.01.006_b0380","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1006\/jmbi.1998.2400","article-title":"Visualizing and quantifying molecular goodness-of-fit: small-probe contact dots with explicit hydrogen atoms","volume":"285","author":"Word","year":"1999","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2014.01.006_b0385","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1006\/jmbi.1998.2401","article-title":"Asparagine and glutamine: using hydrogen atom contacts in the choice of side-chain amide orientation","volume":"285","author":"Word","year":"1999","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2014.01.006_b0390","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1021\/ci300541c","article-title":"Exploring the molecular mechanism of cross-resistance to HIV-1 integrase strand transfer inhibitors by molecular dynamics simulation and residue interaction network analysis","volume":"53","author":"Xue","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.antiviral.2014.01.006_b0395","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1039\/c2mb25157d","article-title":"Understanding the structural and energetic basis of inhibitor and substrate bound to the full-length NS3\/4A: insights from molecular dynamics simulation, binding free energy calculation and network analysis","volume":"8","author":"Xue","year":"2012","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.antiviral.2014.01.006_b0400","article-title":"Computational study on the drug resistance mechanism against HCV NS3\/4A protease inhibitors vaniprevir and MK-5172 by the combination use of molecular dynamics simulation, residue interaction network, and substrate envelope analysis","author":"Xue","year":"2013","journal-title":"J. Chem. Inf. Model"},{"key":"10.1016\/j.antiviral.2014.01.006_b0405","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0969-2126(00)80025-8","article-title":"Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease\u2013helicase","volume":"7","author":"Yao","year":"1999","journal-title":"Structure"},{"key":"10.1016\/j.antiviral.2014.01.006_b0410","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1128\/AAC.05438-11","article-title":"Biochemical study of the comparative inhibition of hepatitis C virus RNA polymerase by VX-222 and filibuvir","volume":"56","author":"Yi","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2014.01.006_b0415","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1093\/bioinformatics\/btl533","article-title":"An algorithm for modularity analysis of directed and weighted biological networks based on edge-betweenness centrality","volume":"22","author":"Yoon","year":"2006","journal-title":"Bioinformatics"},{"key":"10.1016\/j.antiviral.2014.01.006_b0420","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1073\/pnas.0907304107","article-title":"Detecting and understanding combinatorial mutation patterns responsible for HIV drug resistance","volume":"107","author":"Zhang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2014.01.006_b0425","doi-asserted-by":"crossref","first-page":"17253","DOI":"10.1021\/ja053973d","article-title":"Effect of a bound non-nucleoside RT inhibitor on the dynamics of wild-type and mutant HIV-1 reverse transcriptase","volume":"127","author":"Zhou","year":"2005","journal-title":"J. Am. Chem. Soc."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214000187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214000187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T00:50:52Z","timestamp":1538873452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354214000187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":85,"alternative-id":["S0166354214000187"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.01.006","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular modeling and residue interaction network studies on the mechanism of binding and resistance of the HCV NS5B polymerase mutants to VX-222 and ANA598","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}